Beijing Science Sun Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 599.23 million compared to CNY 809.48 million a year ago. Revenue was CNY 599.23 million compared to CNY 809.48 million a year ago.

Net income was CNY 252.62 million compared to CNY 137.71 million a year ago. Basic earnings per share from continuing operations was CNY 0.52 compared to CNY 0.29 a year ago. Diluted earnings per share from continuing operations was CNY 0.52 compared to CNY 0.29 a year ago.